Hearing - Proposed Amendment To Section 25705 Specific Regulatory Levels Posing No Significant Risk: Imazalil

On September 23, 2011, OEHHA published a notice in the California Regulatory Notice Register (Register 2011, No. 38-Z) proposing to establish a specific regulatory level posing no significant risk for Imazalil by amending Title 27, California Code of Regulations, section 25705.

Publication of the prior notice initiated a 45‑day public comment period that was scheduled to close on November 7, 2011.  OEHHA has received a request from an interested party, Environmental Voices, for a public hearing.  A public hearing is scheduled for October 27, 2011 at 10:00 a.m. in the Sierra Hearing Room located at 1001 I Street in Sacramento, CA.  To allow time for the preparation of written public comments after the hearing, OEHHA hereby extends the public comment period on this proposed amendment to 5:00 p.m., Monday, November 21, 2011. Written comments, along with any supporting documentation, may be transmitted via email addressed to mvela@oehha.ca.gov or to:

Ms. Monet Vela
Office of Environmental Health Hazard Assessment
Street Address:  1001 I Street, 23rd Floor
Sacramento, California  95814
Mailing Address:  P.O. Box 4010
Sacramento, California  95812-4010

Fax No.:  (916) 323-2517   
Telephone:  (916) 323-2610

Related Content